Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
05/2003
05/13/2003US6562811 Pyridine derivatives
05/13/2003US6562809 Contraction of coronary arteries may be mediated by its stimulation of the 5-HT1B (formerly 5-HT1D beta); compounds selective for a 5-HT1D receptor
05/13/2003CA2261724C Novel tricyclic n-cyanoimines useful as inhibitors of farnesyl-protein transferase
05/13/2003CA2211681C Novel pyridonecarboxylic acid derivatives or salts thereof and antibacterial agents comprising the same as active ingredient
05/13/2003CA2115443C Azabicyclo arylacetylene and arylenyne oximes as cholinergic agents and methods of treatment
05/13/2003CA2021467C Heterocyclically substituted sulfonylureas, process for their preparation, and their use as herbicides or plant growth regulators
05/08/2003WO2003037901A1 Bridged bicycle (1,4) benzodiazepine vasopressin receptor antagonists
05/08/2003WO2003037896A1 N-azabicyclo-substituted hetero-bicyclic carboxamides as nachr agonists
05/08/2003WO2003037862A1 Amide derivatives and drugs
05/08/2003WO2003037861A1 Use of 2-acylindoles in the treatment of tumors
05/08/2003WO2003037338A2 Modulators of the cholesterol biosynthetic pathway
05/08/2003WO2003037332A1 Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity
05/08/2003WO2003037327A1 N-substituted pyrrolidin derivatives as dipeptidyl peptidase iv inhibitors
05/08/2003WO2003037271A2 Compounds, pharmaceutical compositions and methods of use therefor
05/08/2003WO2003014128A3 Tumour inhibiting cerium compounds
05/08/2003WO2003010511A3 Low resolution surface enhanced raman spectroscopy on sol-gel substrates
05/08/2003WO2002088124A3 Pyrazolo'1,5-a!pyridine derivatives
05/08/2003WO2002009702A8 Use of indole derivatives for the manufacture of a medicament for reducing intracular pressure
05/08/2003US20030088101 E-ring expanded camptothecin derivatives
05/08/2003US20030088094 Novel synthesis and crystallization of piperazine ring-containing compounds
05/08/2003US20030087928 Novel anilide compounds and drugs containing the same
05/08/2003US20030087925 Benzoamide piperidine containing compounds and related compounds
05/08/2003US20030087916 Pyrimidin-4-one compounds
05/08/2003US20030087895 Fused imidazole derivatives as multidrug resistance modulators
05/08/2003US20030087892 Condensed azepines as vasopressin agonists
05/08/2003US20030087881 Quinazoline derivatives used to treat cancer, restenosis, atherosclerosis, endometriosis, and psoriasis
05/08/2003US20030087306 Methods for identifying novel multimeric agents that modulate receptors
05/08/2003CA2465497A1 Bridged bicyclic amino acid-derived (1,4) benzodiazepine vasopressin receptor antagonists
05/08/2003CA2464194A1 N-azabicyclo-substituted hetero-bicyclic carboxamides as nachr agonists
05/08/2003CA2463441A1 Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity
05/07/2003EP1308513A1 Use of polypeptide
05/07/2003EP1308439A1 Proline derivatives and use thereof as drugs
05/07/2003EP1307457A1 Azabicyclic compounds, preparation thereof and use as medicines, in particular as antibacterial agents
05/07/2003EP1307455A2 Inhibitors of alpha-l beta-2 mediated cell adhesion
05/07/2003EP1307454A1 Derivatives of variolin b
05/07/2003EP1307453A2 Dihydronaphthyridine- and dihydropyrrolopyridine-derivated compounds as potassium channel openers
05/07/2003EP1307452A1 Use of polycyclic aromatic compounds for making medicines capable of inhibiting telomerase
05/07/2003EP1307451A2 Process for preparing 2-(4-pyridyl)amino-6-dialkyloxyphenyl-pyrido 2,3-d]pyrimidin-7-ones
05/07/2003EP1307450A2 2-(4-pyrdyl)amino-6-dialkoxyphenyl-pyrido(2.3-d)pyrimidin-7-ones
05/07/2003EP1307443A2 Novel substituted diaryl azepine derivatives as integrin ligands
05/07/2003EP1307204A1 Protease inhibitors
05/07/2003EP1307192A1 New use of angiotensin ii antagonists
05/07/2003EP1307191A2 Use of indole derivatives for the manufacture of a medicament for reducing intracular pressure
05/07/2003EP1033987B1 Aqueous suspensions of submicron 9-hydroxyrisperidone fatty acid esters
05/07/2003EP0981527B1 Salt of naphthyridine carboxylic acid derivative
05/07/2003EP0966454B1 Disubstituted bicyclic heterocycles, their production and use as medicaments
05/07/2003EP0912520B1 Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
05/07/2003EP0841929B1 Quinolones and their therapeutic use
05/07/2003EP0765314B1 Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators
05/07/2003EP0749433B1 (4,4-difluorobut-3-enylthio)-substituted heterocyclic or carbocyclic ring compounds having pesticidal activity
05/07/2003CN1416430A 4-oxo-1,4-dihydro[1,8]naphthyridine-3-carboxamides as antiviral agents
05/07/2003CN1416421A New CCRS modulators: benzimidazoles or benzotriazoles
05/07/2003CN1415619A Compound for adjusting functional activity of vascular endothelial cell, its preparation method as well as usage
05/07/2003CN1107676C Cationic imide as polypeptide condensing agent and its synthesis
05/07/2003CN1107502C Prepn. method for medicinal compsn. contg. hydrogonated pyridine derivative as active components
05/06/2003US6559313 Adenosine derivatives such as (1S,2R,3S,4R)-2,3-dihydroxy-4-(6-(1-(4-trifluormethylpyridin-2-yl)pyrrolidin-3(S)-yl-amino)purin-9-yl)cyclopentanecarboxylic acid isopropylamide
05/06/2003US6559303 Bridgehead atoms are bonded to one or more bridges that interconnect one or more ring systems thereby forming a large cyclic structure. Located in each bridge are two or more nitrogenous moieties that are derivatized with chemical
05/06/2003US6559169 For therapy of depression, anxiety, panic disorder, post-traumatic stress disorder, premenstrual dysphoric disorder attention deficit disorder,obsessive compulsive disorder, obesity, eating disorders, sexual dysfunction
05/06/2003US6559167 Prodrugs of the pyridyl methyl sulfinyl benzimidazole type proton pump inhibitor drugs have a hydrolyzable arylsulfonyl or heteroarylsulfonyl group attached to the benzimidazole nitrogen. The prodrugs of the invention hydrolyze under
05/06/2003US6559163 Agonists, antagonists or inverse agonists for GABAA brain receptors; useful in diagnosis and treatment of anxiety, depression
05/06/2003US6559161 Cytotoxic pyrido[2,3,4-ki]acridine derivatives, their preparation and their therapeutic use
05/06/2003US6559159 Kappa opioid receptor ligands
05/06/2003US6559152 6-substituted pyrazolo[3,4-d]pyrimidin-4-ones useful as cyclin dependent kinase inhibitors
05/06/2003US6559150 Growth hormone secretagogues
05/06/2003US6559145 Heterocycle carboxamides as antiviral agents
05/06/2003US6559141 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
05/06/2003US6558435 Reactive crystallization method to improve particle size
05/06/2003CA2268166C Pyrrolo[3,2-c]quinoline derivatives containing haloalkoxy group and pharmaceutically acceptable salts thereof
05/06/2003CA2189698C Substituted 1,2,3-triazol-3-ones
05/02/2003EP1306373A1 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient
05/02/2003EP1305313A1 Fused heterocyclic derivatives as phosphodiesterase inhibitors
05/02/2003EP1305308A1 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
05/02/2003EP1305294A2 Imidazolyl derivatives
05/02/2003EP1305048A2 Inhibitors of cellular efflux pumps of microbes
05/02/2003EP1305028A2 Antimicrobial biaryl compounds
05/02/2003EP1228376A4 Fluorescent compounds for use in industrial water systems
05/02/2003EP1212103A4 4-fluoroalkyl-3-halophenyl nortropanes
05/02/2003EP1196167A4 Method of reducing neuronal injury or apoptosis
05/02/2003EP1185516B1 Substituted phenylcyclohexane carboxylic acid amides that have an adenosine uptake inhibiting effect
05/02/2003EP1086103B1 Pyrido 2,3-b]indolizine derivatives and aza analogues thereof; crf 1 specific ligands
05/02/2003EP1028950B1 7-substituted quinazolin-2,4-diones useful as antibacterial agents
05/02/2003EP1021448B1 TRICYCLIC COMPOUNDS HAVING ACTIVITY AS Ras-FPT INHIBITORS
05/02/2003EP0901482B1 Benzofuran carboxamides and their therapeutic use
05/02/2003EP0724387B1 Angiotension ii receptor antagonists for the treatment of chronic anti-inflammatory diseases
05/02/2003EP0662078B1 Reagents for peptide couplings
05/01/2003WO2003035649A1 Imidazopyridine compounds as 5-ht4 receptor modulators
05/01/2003WO2003035643A1 Pyrazolyl-substituted heterocycles and their use as phytosanitary products
05/01/2003WO2003035635A1 6-hydroxy isoflavones, derivatives and medicaments involving same
05/01/2003WO2003035625A1 Substituted indazole compounds for the treatment of inflammation
05/01/2003WO2003035624A1 Quinoline compound
05/01/2003WO2003035615A2 Tyrosine kinase inhibitors
05/01/2003WO2003035602A1 Lipid modulators
05/01/2003WO2003035076A1 Dihydroxypyrimidine carboxamide inhibitors of hiv integrase
05/01/2003WO2003035074A1 Drugs comprising combination of triazaspiro[5,5]undecane derivative with cytochrome p450 isozyme 3a4 inhibitor and/or p-glycoprotein inhibitor
05/01/2003WO2003035065A1 Benzimidazoles and analogues and their use as protein kinases inhibitors
05/01/2003WO2003034987A2 Androgen receptor modulators and methods of use thereof
05/01/2003WO2003008412A3 Hetero-bicyclic crf antagonists
05/01/2003WO2002099388A3 Benzodiazepine bradykinin antagonists
05/01/2003WO2002094840A3 Tricyclic dihydro-quinoline derivatives, method for preparing same and pharmaceutical compositions containing same
05/01/2003WO2002072581A3 Pyrazolopyriadine derivatives